Ebola Vaccination: If Not Now, When?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of Internal Medicine

• Publication date

  2014-11-18

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.7326/M14-1904PMID 25141813PMCID PMC4316820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge

  2011cited by this paper
• Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses

  2011cited by this paper
• A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus

  2011cited by this paper
• Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

  2009cited by this paper
• Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates

  2008cited by this paper
• Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

  2007cited by this paper
• Effective Post-Exposure Treatment of Ebola Infection

  2007cited by this paper
• A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus Challenge

  2006cited by this paper
• A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial

  2006cited by this paper
• The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

  1999cited by this paper

• Perceptions and Rumors About the Ebola Virus Disease Vaccine in the Ituri and Kivu Provinces of the Democratic Republic of Congo

  2023cites this paper
• Experimental Study of Potential CD8+ Trivalent Synthetic Peptides for Liver Cancer Vaccine Development Using Sprague Dawley Rat Models

  2022cites this paper
• International Journal of Current Microbiology and Applied Sciences

  2020cites this paper
• Novel epitope based peptides for vaccine against SARS-CoV-2 virus: immunoinformatics with docking approach

  2020cites this paper
• Experimental Analysis of T-Cell Epitopes for Designing Liver Cancer Vaccine Predicted by System Level Immunoinformatics Approach.

  2020cites this paper
• Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24

  2019cites this paper
• Lessons learned from engaging communities for Ebola vaccine trials in Sierra Leone: reciprocity, relatability, relationships and respect (the four R’s)

  2019cites this paper
• Vertical dynamics of Ebola with media impact

  2019cites this paper
• Ebola vaccination in the Democratic Republic of the Congo

  2019cites this paper
• Control fast or control smart: When should invading pathogens be controlled?

  2018cites this paper
• A MATHEMATICAL MODEL FOR EBOLA EPIDEMIC WITH SELF-PROTECTION MEASURES

  2017cites this paper
• Ebola virus: A gap in drug design and discovery ‐ experimental and computational perspective

  2017cites this paper
• Ebola virus disease: Essential clinical knowledge

  2017influential citation
• Liver Disease Associated With Systemic Viral Infection

  2017cites this paper
• Quantifying ethical tradeoffs for vaccine efficacy trials during severe epidemics

  2017cites this paper
• An Update on Ebola Virus Epidemiology and Experimental Modalities

  2016cites this paper
• Recent advances in the development of vaccines for Ebola virus disease.

  2016cites this paper
• A review on West African Ebola epidemic dynamics models

  2016cites this paper
• Ebola, gender and conspicuously invisible women in global health governance

  2016cites this paper
• Laboratory diagnosis of Ebola virus disease and corresponding biosafety considerations in the China Ebola Treatment Center

  2016cites this paper
• Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings

  2016cites this paper
• AN OVERVIEW OF EBOLA. AN EMERGING VIRUS

  2015cites this paper
• Journal Roundup: Ebola, antibiotic use and abuse, and the usual suspects

  2015cites this paper
• Effect of Ebola progression on transmission and control in Liberia.

  2015cites this paper
• Modeling the effect of comprehensive interventions on Ebola virus transmission

  2015cites this paper
• Tactics and Strategies for Managing Ebola Outbreaks and the Salience of Immunization

  2015cites this paper
• Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.

  2015cites this paper
• Rhetoric, Ebola, and Vaccination: A Conversation Among Scholars

  2015influential citation
• Harnessing Case Isolation and Ring Vaccination to Control Ebola

  2015cites this paper
• Epitope‐based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study

  2015cites this paper
• Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola

  2015cites this paper
• EBOLA VIRUS OUTBREAK IN WEST AFRICA: AN OVERVIEW

  2015cites this paper
• The Ebola menace: Epidemic, evidence and expectations

  2015cites this paper
• Ébola y virus emergentes

  2015cites this paper
• Ebola Virus Outbreak: The Present Situation in South East Asia Perspective

  2014cites this paper
• Strategies for containing Ebola in West Africa

  2014cites this paper
• Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis.

  2014cites this paper
• Ebola in West Africa: be aware and prepare

  2014cites this paper
• Ebola virus (EBOV) infection: Therapeutic strategies

  2014cites this paper
• Ebola control: effect of asymptomatic infection and acquired immunity.

  2014cites this paper